| CSL Behring AG - Berinert IV 500, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 51950 | | 02 | | Berinert IV 500 | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B06AC01 | | C1-Inhibitor, Plasma Derived | | 09.04.2002 | | |
|
| Composition |
| Praeparatio cryodesiccata: proteina plasmatis humani 65 mg corresp. C1-inhibitor humanus 500 U.I., glycinum, natrii chloridum, natrii citras dihydricus pro vitro corresp. natrium 48.6 mg.
Solvens: aqua ad iniectabile q.s. ad solutionem pro 10 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Proteina Plasmatis Humani | 65 mg correspond C1-inhibitor Humanus 500 UI |
| | BAG: Active Agent | Dose |
|---|
| C1-esterasi Inhibitor Humanus | 500 UI |
| | | | Inactive agents |
|---|
| Glycin | | Sodium Chloride | | Natrii Citras Dihydricus |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 500 / 0 UI | 678.25 | 736.90 | B | SL | Yes |
|
